Feb 5, 2020 | Press Releases
MARLBOROUGH, Mass., Feb. 5, 2020 — Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today...
Jan 14, 2020 | Press Releases
MARLBOROUGH, Mass., Jan. 14, 2020 — Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today...
Jan 6, 2020 | Press Releases
– Management will be hosting meetings at the LifeSci Advisors Corporate Access Event in San Francisco during the weekMARLBOROUGH, Mass., Jan. 6, 2020 — Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of...
